Deadline for Late Breaking Research Presentations submissions:
August 26, 2013 at 11:59 pm Pacific Time
CALL FOR ABSTRACTS
Late Breaking Research Presentations
Overview: The Plastic Surgery Foundation is calling for abstracts of Late Breaking Research for Plastic Surgery The Meeting 2013 in San Diego, CA. Accepted submissions will be presented at a session on Monday, October 14 from 11:15 a.m. - 12:00 p.m. Preference will be given to prospective multi-institutional trials, the content of which will not have been published by any journal or previously presented by the time of the Plastic Surgery 2013 Meeting. The concept is to provide attendees with “late-breaking” trial data.
Abstracts must be submitted by 11:59 p.m. Pacific on Monday, August 26, 2013. Abstracts may have up to a maximum of 375 words.
Please be sure to include the following sections and responses to the questions with the submission. The title, authors, and affiliations are not included in the overall character limit.
What quality gap (limitation or problem) with the practice of plastic surgery does this research address?
In what way might the results of this project supplement or inform our clinical or research knowledge or strategies?
Session Date – Monday, October 14, 2013
Session Time – 11:15 a.m. - 12:00 p.m.
Session Length – 45 minutes total
Call for Abstracts Open – August 2 to August 26
Review Period – August 29 to September 9
Applicant Notification – September 13
Guidelines for Late Breaking Research Presentations
Late Breaking Research Presentation sessions are innovative and provide the latest breakthroughs in plastic surgery research. These sessions provide notable exposure and recognition for studies likely to have a significant impact on clinical practice.
Preparing the Abstract
An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
The submitting author is designated as the primary/presenting author. You may rearrange the order of the authors; however, always list the senior author last.
Create your abstract text in a word processing program prior to beginning your online submission. Use that program to check the word count. Abstract text (which does not include title or authors) is limited to 375 words or less. This includes the text plus any graphics, but should not contain title or author information; these are specific elsewhere in the submission process. Abstracts not conforming to the prescribed format will not be considered for presentation.
Abstract text must include the following:
The concise purpose.
The methods and materials used. Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
Experience including the number of cases and follow-up. Only final data should be submitted.
Summary of results.
Reasonable and understandable conclusions.
Use generic drug names.
Do not begin sentences with numerals.
Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
Do not include references, credits or grant support.
Do not include the names or personal information of any patient participating in the study or trial.
Relevant photographs/illustrations may be submitted to clarify and/or support the work. Adhere to the following technical points:
Up to 2 images may be submitted.
Multi-panel images will not be accepted.
Do not label with author name(s).
Submit figures in color if at all possible. Black and white digital images should be in grayscale mode.
Figures should be submitted in high resolution JPEG or TIFF.
Figures should be saves in “RGB’ mode.
Figures should have a resolution of 300 dpi or greater.
Physical dimensions of figures should be 3.25” wide. As a general rule, the bigger, the better.
Abstracts may be returned to authors if their submitted figures do not comply with the guidelines.
Alterations can be made to any part of the abstract until the submission deadline. Simply log in with the numerical user id and password provided by the system. Once the deadline has past, you will no longer have access to the system.
Online disclosures will be collected for all authors. Disclosures are required for all authors. Your submission will not be considered for review if disclosures are missing for any authors.
All sources of funds supporting the work and a statement of financial interest, if any, must be included for each author, along with a list of all products, devices, drugs, etc., used.
Each author must disclose at the time of submission any commercial associations or financial disclosures that might post or create a conflict of interest with the information presented in any submitted abstract. Such associations include consultancies, stock ownership, or other equity interests, patent licensing arrangements, and payments for conducting or publicizing a study described in the abstract.
Notice of acceptance or non-acceptance will be forwarded in mid-September to the presenter only. Presenters are responsible for notifying any co-authors. All correspondence will be sent to the email address listed for the presenter. Please check this email address regularly for submission updates and notify ASPS Staff if it changes.
Guidelines for abstract presentation will be provided to the presenting author of accepted abstracts in mid-September.
All oral presentations must be in electronic format. Submit electronic presentations in advance of the session start time. Instructions for presentation upload will be provided upon acceptance.
The ASPS reserves the right to all video or audio recordings of presentations.
Submit all abstracts in English.
Authors should not "split" data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
Material presented must be original. No portion of abstracts submitted can be from previously presented material, in any publication, in either print or online mediums. Papers previously presented at local or regional meetings are acceptable only if the presentation was not published in an abstract supplement or book, in either print or online mediums. The work covered by the abstract must not have been published (manuscript or abstract) before the date and time of presentation (October 14, 2013).
Abstract grading is blinded and abstracts are selected on the basis of scientific merit.
All presentations and question-and-answer sessions will be conducted in English.
The presenting author of an accepted abstract must register for the meeting. Abstract presenters need to register in the appropriate category and pay the appropriate fees under each category.
All other expenses (e.g. airfare, lodging) associated with the submission and presentation of an abstract are the responsibility of the presenter.
For questions regarding the submission guidelines, please contact Katie Crotty.
Presenters please note: Due to the late timeline for submissions, presenter names and abstract titles will not be printed in the official program.
If you have already submitted an abstract title and you wish to view, resume, edit, or withdraw that submission, log in below using the access codes already provided to you:
Technical support may be obtained by calling (401) 334-0220 between 8:30 a.m and 6:00 p.m. ET, Monday-Friday, or at all times by contacting tech support. For all other information regarding content, acceptance process, or abstract administration, please forward a message via email to email@example.com.